Crossmark

Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis

Crossref DOI link: https://doi.org/10.1186/s12974-022-02550-7

Published Online: 2022-07-14

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Dong

Zhang, Shishuang

Ge, Xintong

Yin, Zhenyu

Li, Meimei

Guo, Mengtian

Hu, Tianpeng

Han, Zhaoli

Kong, Xiaodong

Li, Dai

Zhao, Jing

Wang, Lu

Liu, Qiang

Chen, Fanglian

Lei, Ping
Funding

Funding for this research was provided by:

Tianjin Municipal Bureau of Public Health (KJ20177, TJWJ2021QN005, ZC20184)

Natural Science Foundation of Tianjin City (19JCQNJC10200)

National Natural Science Foundation of China (82071394, 82102318, 82072166)
License Information

Text and Data Mining valid from 2022-07-14

Version of Record valid from 2022-07-14
More Information

Article History

Received: 14 May 2022

Accepted: 6 July 2022

First Online: 14 July 2022

Declarations

:

: The animal study was reviewed and approved by Tianjin Medical University Animal Care and Use Committee.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below